Statements & Guidelines
We are the only national organization dedicated to the liver and liver disease, with experts available to media for questions seven days a week. If you are a member of a news or media organization, please contact Stacey Harris at our media relations desk:
By phone: (917) 697-7746
By e-mail: email@example.com
Posted on December 10th 2013
Treatments With Few Serious Side Effects Strengthen Case for Increased Screening, Which Could Save Many Lives
Love Your Liver Infographic
Posted on October 17th 2013
The costs of liver disease are staggering. Read more below:
Raising Awareness for Non-Alcoholic Fatty Liver Disease (NAFLD)
Posted on June 16th 2013
We're focusing our efforts for June on raising awareness about the dangers and prevalence of Non-Alcoholic Fatty Liver Disease. Check our new infographic below, which features important highlights of the disease. For more information, please visit our NAFLD Disease Information Page.
LIVEr Champion: Lindsey Boynton
Posted on May 22nd 2013
May is Hepatitis Awareness Month, and in honor of this very important month, the American Liver Foundation would like to share a story of survival, courage, and overcoming obstacles.
Ryan Agnew – Liver Transplant Recipient
Posted on April 14th 2013
April is Donor Awareness Month and, in honor of this very special month, the American Liver Foundation would like to share a story of hope, survival and the ultimate gift of life.
Just an Ordinary Guy?
Posted on April 7th 2013
This Boston Globe story may be about an ordinary guy, but read about how he raised $1 million for the American Liver Foundation and his buddy Zac.
The Rocky Mountain Division's recent Flavors of Denver event received extensive media coverage in the following publications:
Feature story citing Executive Director Joseph McCormack as well as patient advocates James and Carleen McGuffey, appeared in the May 21, 2014 issue. to see pictures from the event, click here. To read more about the McGuffeys, clickhere.
The Denver Westword- Weekly newspaper featured a photo gallery of the event.
Hillel Tobias, MD, PhD, co-chair of ALF’s national medical advisory committee and a member of the national board of directors, was cited in a segment about the costs-benefits of the new hepatitis C treatment, Sovaldi. The program aired on May 22, 2014. Dr. Tobias is a clinical professor in the Department of Gastroenterology at NYU Langone Medical Center.
National Medical Advisory Committee Member, Andrew Muir, MD, MHS, an associate professor of medicine and clinical director of hepatology at Duke University Medical Center, discussed how hepatitis C is often symptomless. American Liver Foundation patient advocate Charlotte Stewart shared her experiences of living with a hepatitis C diagnosis.
ALF National Board Chair Tom Nealon was quoted in an article about the new medications for hepatitis C and those coming to market.
Dr. Hugo Vargas, member of ALF’s national medical advisory committee and chair of the Division of Hepatology at the Mayo Clinic (Phoenix), was prominently featured in an article about hepatitis C research.
Paul Bolter, ALF’s Greater York Division’s community outreach and education manager, was featured in coverage of the May 15, 2014, viral hepatitis awareness press conference held on the steps of City Hall. Bolter spoke about living with hepatitis C.
Tom Nealon, chairman of the ALF board and marathon runner, was featured on Boston’s local CBS affiliate on April 8th about runners who did not finish last year’s Boston Marathon and their plans for completing the 2014 race.
An article and corresponding video about the Connecticut division’s Flavors event was featured in the April 8th edition. It mentions how the event supports the American Liver Foundation. The division also produced a special video about its mission that aired at the event. Click here to watch it.
Hillel Tobias, MD, PhD, co-chair of ALF’s national medical advisory committee and a member of the national board of directors, along with ALF patient advocate Paul Bolter, was cited in the April 11th issue. The article focused on the success of Sovaldi treatment for hepatitis C.
FOX TV Nashville
ALF's Mid-South division executive director, AJ Miller, appeared on a segment to discuss the work of the American Liver Foundation Click here to watch it. In another segment, the mother of a baby with liver disease was featured. Click here to watch. The program highlighted the upcoming Flavors event.
Arizona Republic and Northeast Phoenix Republic
These two newspapers ran articles about the Phoenix Liver Life Walk and the event’s fundraising goals.
The Desert Southwest Division’s Phoenix Liver Life Walk was profiled on a broadcast segment that aired on April 12th. The program featured interviews with the division’s Liver Life Champion and Hamilton Baiden, president of the Desert Southwest Division’s board and a member of its national board of directors.
Great Lakes Division board member Debbie Panarese appeared on the station’s “Living Healthy Chicago” program on April 13th. She talked about living with hepatitis C and her work with the American Liver Foundation. The segment appeared on the station’s website www.livinghealthytv.com. Additionally, the piece re-aired on Chicago Land TV (CLTV).
Tom Nealon, was also the subject of a profile in the April 28th issue of WorldRunning.com. The article describes his devotion to a young boy with biliary atresia and how that inspired him to raise nearly $1.5 million for the American Liver Foundation.
Dr. Hugo Vargas, member of ALF’s national medical advisory committee and chair of the Division of Hepatology at the Mayo Clinic (Phoenix), discussed the new era in hepatitis C treatments on the May 12th program. NPR’s Morning Edition is the most listened-to news radio program in the country.
The American Liver Foundation was cited in a recent article about hepatitis C and a new Senate bill.
Dr. Jorge Rakela, associate director of the Center for Regenerative Medicine at the Mayo Clinic Hospital in Phoenix and member of the American Liver Foundation’s Desert Southwest medical advisory committee, discussed 3D printing of livers and other human organs.
ALF national medical advisory committee member, Dr. Hugo Vargas, chair of the Division of Hepatology at the Mayo Clinic in Phoenix and professor of medicine at the Mayo Clinic College of Medicine, was interviewed for NPR’s Morning Edition program about the cost of new hepatitis C medications and patient access. Air date to be determined.
Flavors of Connecticut was featured in a segment that aired on the station’s Better Connecticut TV segment.
Phil Scarfo, ALF’s national director of education and training and a transplant recipient, was recently featured in a profile about people living with liver disease.
Dr. Clark Kulig, member of ALF’s Rocky Mountain medical advisory committee, discussed the results of a study showing that giving up alcohol for one month had health benefits for the liver. The article will run in the next few weeks.
Hillel Tobias, MD, PhD, co-chair of ALF’s national medical advisory committee and a member of the national board of directors, discussed the progress in hepatitis treatment in the February 24, 2014 edition of The New York Times, Personal Health column of the Science Times section. The article also profiled his patient, who is responding dramatically to new treatments, as well as another ALF patient advocate who shared his experiences. Dr. Tobias is a clinical professor in the Department of Gastroenterology at NYU Langone Medical Center.
Nancy Reau, MD, co-chair of ALF’s national medical advisory committee and a member of the national board of directors, offered New Year’s tips on how to keep your liver healthy. Dr. Reau is an associate professor of medicine at the University of Chicago.
Nikolaos Pyrsopolous, MD, chief of gastroenterology and hepatology and medical director of liver transplantation at Rutgers University, dispelled the myths and provided the facts about the public’s risk for liver disease, including viral hepatitis, fatty liver disease and cirrhosis. The segment airs on foxnews.com. Dr. Pyrsopolous is a member of ALF’s Greater New York Division medical advisory committee.
Tom Nealon, ALF’s national board chair, was profiled about his work at the American Liver Foundation and promising new treatments for hep C patients.